We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Middleby
MIDD
$6.08B
| $14.5M | 0.01% |
112,888
-3,508
| -3% | -$492K |
|
1227
Mativ Holdings
MATV
$711M
| $14.4M | 0.01% |
652,696
+533,917
| +450% | +$12.2M |
|
|
PPLI
1228
People Inc
PPLI
$3.1B
| $14.4M | 0.01% |
316,988
-1,227,568
| -79% | -$69.1M |
|
|
LNW
1229
DELISTED
Light & Wonder
LNW
| $14.4M | 0.01% |
334,833
-102,431
| -23% | -$5.06M |
|
1230
Synaptics
SYNA
$4.15B
| $14.3M | 0.01% |
144,735
+3,492
| +2% | +$433K |
|
1231
James River Group Holdings
JRVR
$217M
| $14.3M | 0.01% |
627,716
-2,348
| -0.4% | -$56K |
|
|
SEM
1232
DELISTED
Select Medical
SEM
| $14.3M | 0.01% |
1,202,413
-192,033
| -14% | -$2.73M |
|
|
MBNE
1233
DELISTED
State Street Nuveen Municipal Bond ESG ETF
MBNE
| $14.3M | 0.01% |
499,998
| – | – |
|
1234
Globalstar
GSAT
$10.8B
| $14.3M | 0.01% |
598,974
+45,875
| +8% | +$1.11M |
|
1235
Coca-Cola Consolidated
COKE
$12.8B
| $14.3M | 0.01% |
346,100
-6,790
| -2% | -$334K |
|
1236
LSB Industries
LXU
$693M
| $14.2M | 0.01% |
998,491
+778,220
| +353% | +$11M |
|
|
SMAR
1237
DELISTED
Smartsheet Inc.
SMAR
| $14.2M | 0.01% |
413,732
-185,571
| -31% | -$6.29M |
|
1238
Haemonetics
HAE
$4B
| $14.2M | 0.01% |
191,356
+6,350
| +3% | +$456K |
|
1239
Idacorp
IDA
$8.2B
| $14.2M | 0.01% |
143,006
-7,657
| -5% | -$835K |
|
|
ESMT
1240
DELISTED
EngageSmart, Inc.
ESMT
| $14.2M | 0.01% |
684,247
+285,945
| +72% | +$5.6M |
|
1241
New York Times
NYT
$10.2B
| $14.1M | 0.01% |
491,921
-80,190
| -14% | -$2.45M |
|
|
BZUN
1242
Baozun
BZUN
$172M
| $14.1M | 0.01% |
2,249,555
+178,000
| +9% | +$1.53M |
|
1243
Encompass Health
EHC
$12.4B
| $14.1M | 0.01% |
312,158
-91,216
| -23% | -$4.56M |
|
1244
Westamerica Bancorp
WABC
$1.37B
| $14.1M | 0.01% |
268,900
+118,782
| +79% | +$6.77M |
|
1245
Leggett & Platt
LEG
$1.31B
| $14M | 0.01% |
422,248
-12,955
| -3% | -$492K |
|
1246
Marcus & Millichap
MMI
$1.19B
| $14M | 0.01% |
427,725
-29,463
| -6% | -$1.11M |
|
1247
APi Group
APG
$18B
| $14M | 0.01% |
1,583,096
+24,662
| +2% | +$263K |
|
1248
Minerals Technologies
MTX
$2.34B
| $14M | 0.01% |
283,404
-8,556
| -3% | -$520K |
|
1249
Mohawk Industries
MHK
$9.22B
| $14M | 0.01% |
153,451
-7,709
| -5% | -$895K |
|
1250
Commerce Bancshares
CBSH
$8.5B
| $14M | 0.01% |
256,832
-10,607
| -4% | -$605K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.